Learn About Abdominal Obesity Metabolic Syndrome

What is the definition of Abdominal Obesity Metabolic Syndrome?
Abdominal obesity metabolic syndrome is a disease that is influenced by both genetic and environmental factors characterized by a clustering of insulin resistance, high levels of insulin, abnormal blood fats (lipids), high blood pressure, abdominal obesity, glucose intolerance or non-insulin dependent diabetes mellitus, and an increased risk of adverse cardiovascular events. There are different types of abdominal obesity metabolic syndrome, such as abdominal obesity metabolic syndrome 1 or 4. Factors that influence the development of abdominal obesity metabolic syndrome include age, smoking, alcohol, diet, and physical inactivity. Abdominal obesity metabolic syndrome occurs most often in Mexican American women.
Save information for later
Sign Up
What are the symptoms of Abdominal Obesity Metabolic Syndrome?
Symptoms of abdominal obesity metabolic syndrome may include chest pain; radiating pain in chest, jaw, or down left arm (angina pectoris); swelling; abdominal obesity; high blood pressure; high blood triglycerides and low high-density lipoprotein levels; high fasting glucose levels; type 2 diabetes; coronary heart disease (plaque build-up in arteries; CHD); heart attack; and cardiac death.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Abdominal Obesity Metabolic Syndrome?
Treatment for abdominal obesity metabolic syndrome focuses first on lifestyle changes, such as weight loss, exercise, healthy diet, and quitting smoking. Medications for treating abdominal obesity metabolic syndrome may include diabetes drugs; statins to lower blood lipids (fats), such as atorvastatin; blood pressure medications; and blood-thinning medications, such as aspirin or clopidogrel to prevent blood clots.
Who are the top Abdominal Obesity Metabolic Syndrome Local Doctors?
Elite
Highly rated in
39
conditions

Nippon Medical School

Sendagi, JP 

Tomoyuki Kawada is in Sendagi, Japan. Kawada is rated as an Elite expert by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. They are also highly rated in 39 other conditions, according to our data. Their top areas of expertise are Abdominal Obesity Metabolic Syndrome, Metabolic Syndrome, Obstructive Sleep Apnea, and Maturity Onset Diabetes of the Young.

Elite
Highly rated in
18
conditions

University Of Isfahan

Isfahan, IR 

Roya Kelishadi is in Isfahan, Islamic Republic of Iran. Kelishadi is rated as an Elite expert by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. She is also highly rated in 18 other conditions, according to our data. Her top areas of expertise are Congenital Hyperinsulinism, Obesity in Children, Metabolic Syndrome, and Obesity.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
15
conditions

School Of Medicine, Shahid Beheshti University Of Medical Sciences

Valiabad-e Beheshti, IR 

Parvin Mirmiran is in Valiabad-e Beheshti, Islamic Republic of Iran. Mirmiran is rated as an Elite expert by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Obesity, Metabolic Syndrome, Abdominal Obesity Metabolic Syndrome, and Type 2 Diabetes.

What are the latest Abdominal Obesity Metabolic Syndrome Clinical Trials?
Exercise Effects on Adipose Tissue Structure and Function
Match to trials
Find the right clinical trials for you in under a minute
Get started
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
What are the Latest Advances for Abdominal Obesity Metabolic Syndrome?
Type 1 diabetes and subcutaneous insulin resistance syndrome treated with pancreas transplantation.
Sumac fruit supplementation improve glycemic parameters in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis.
Tired of the same old research?
Check Latest Advances
Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.